Compare leading AI-powered diagnostic, imaging and workflow solutions transforming pathology practice worldwide.
Detailed profiles of the leading AI companies building diagnostic, screening and biomarker tools for clinical pathology.
New York, USA
Products: Paige Prostate, Paige Breast, FullFocus
Clinical Focus: Prostate cancer detection, breast cancer screening
Regulatory: FDA 510(k) cleared (first AI in pathology, 2021); CE-IVD marked
Technology: Deep learning on whole slide images; trained on Memorial Sloan Kettering data
Partnerships: Memorial Sloan Kettering Cancer Center, Microsoft
Integration: Compatible with major LIS platforms and scanners
Boston, USA
Products: AISight, PathExplore
Clinical Focus: Biomarker quantification, clinical trial pathology, companion diagnostics
Regulatory: Clinical trials focus; regulatory submissions in progress
Technology: Multi-modal AI for tissue analysis and biomarker scoring
Partnerships: Bristol-Myers Squibb, Roche, Novartis
Integration: Cloud-based platform; scanner-agnostic
Tel Aviv, Israel
Products: Galen Platform (Galen Prostate, Galen Breast, Galen Gastric)
Clinical Focus: Prostate, breast, and gastric cancer detection
Regulatory: CE-IVD marked; clinical deployment across European laboratories
Technology: CNN-based analysis; claims 99%+ sensitivity for cancer detection
Partnerships: Multiple European hospital networks
Integration: Integrates with Philips, Hamamatsu, Leica scanners and major LIS
Seoul, South Korea
Products: Lunit SCOPE (PD-L1, HER2, Immune Phenotyping)
Clinical Focus: PD-L1 scoring, HER2 quantification, immune cell phenotyping
Regulatory: CE-IVD marked
Technology: Deep learning for IHC biomarker scoring; strong in companion diagnostics
Partnerships: Guardant Health, multiple oncology networks
Integration: Cloud and on-premise deployment options
Helsinki, Finland
Products: Aiforia Create, Aiforia Clinical
Clinical Focus: Custom AI model training, tissue quantification, research analytics
Regulatory: CE-IVD (Aiforia Clinical); research use (Aiforia Create)
Technology: Cloud-based deep learning platform; no-code model training interface
Adoption: Used by 100+ pharmaceutical and academic organisations worldwide
Integration: Scanner-agnostic; supports all major WSI formats
Philadelphia, USA
Products: Concentriq AP-Dx
Clinical Focus: Digital pathology workflow management with integrated AI applications
Regulatory: FDA and CE pathway for enterprise deployment
Technology: Enterprise-grade platform combining image management, workflow orchestration, and AI
Deployment: Cloud and hybrid deployment for health systems
Integration: Open architecture; supports third-party AI algorithm integration
Hamamatsu, Japan
Products: NanoZoomer series (S360, S60, XR) + AI analysis modules
Clinical Focus: Whole slide scanning hardware with integrated AI software modules
Regulatory: CE-IVD (scanners); FDA 510(k) cleared scanners
Technology: High-speed line-scanning optics combined with proprietary AI analysis
Market Position: Largest scanner install base globally
Integration: NDP.serve image management; open API for third-party AI
Linköping, Sweden
Products: Sectra Digital Pathology (part of Sectra Medical PACS)
Clinical Focus: Enterprise workflow, reporting, AI integration layer for pathology
Regulatory: CE marked; deployed across UK NHS and Scandinavian health systems
Technology: PACS-integrated digital pathology with vendor-neutral AI marketplace
Deployment: Strong in Scandinavia, UK NHS, and European health networks
Integration: Scanner-agnostic; integrates with radiology PACS, LIS, and EHR systems
Comparative overview of major whole slide imaging platforms used in clinical and research pathology.
| Scanner | Manufacturer | Speed (slides/hr) | Resolution | Scanning Modes | Price Tier | AI Integration |
|---|---|---|---|---|---|---|
| Aperio AT2 | Leica Biosystems | Up to 80 | 0.25 μm/pixel (40×) | Brightfield | Premium | Leica AI ecosystem + open API |
| Aperio GT 450 | Leica Biosystems | Up to 120 | 0.25 μm/pixel (40×) | Brightfield, continuous loading | Premium | Full AI integration via Aperio eSlide Manager |
| NanoZoomer S360 | Hamamatsu | Up to 120 | 0.23 μm/pixel (40×) | Brightfield, fluorescence | Premium | NDP.serve + third-party AI |
| NanoZoomer S60 | Hamamatsu | Up to 40 | 0.23 μm/pixel (40×) | Brightfield, fluorescence | Mid-range | NDP.serve + third-party AI |
| IntelliSite Ultra Fast Scanner | Philips | Up to 140 | 0.25 μm/pixel (40×) | Brightfield | Premium | Philips AI ecosystem (FDA cleared for primary Dx) |
| Pannoramic SCAN II | 3DHISTECH | Up to 100 | 0.12 μm/pixel (up to 100×) | Brightfield, fluorescence, FISH | Mid-range | CaseViewer + third-party integration |
| DP 200 | Roche / Ventana | Up to 80 | 0.25 μm/pixel (40×) | Brightfield | Premium | uPath enterprise software + Roche AI |
| Ocus | Grundium | Up to 6 | 0.25 μm/pixel (40×) | Brightfield | Portable / Budget | Cloud AI via open API; designed for point-of-care |
Specifications are indicative and reflect manufacturer-published data as of July 2026. Contact manufacturers for current product specifications and clinical validation status.
Tools for annotating whole slide images, building training datasets and developing custom AI models for pathology research.
Open-source platform for whole slide image analysis. Extensive annotation tools, scripting via Groovy, built-in machine learning classifiers, and active community support. Widely adopted in academic research.
Automated Slide Analysis Platform. Lightweight, fast open-source viewer and annotation tool developed by the Computational Pathology Group at Radboud University Medical Center. Supports large WSI files efficiently.
Enterprise data labelling platform with support for medical imaging and pathology workflows. Features include collaborative annotation, quality assurance, model-assisted labelling, and dataset management.
AI-powered annotation platform with auto-annotation capabilities for pathology images. Supports polygon, brush and semantic segmentation tools with model-in-the-loop training workflows.
Web-based slide scoring and annotation platform designed for pathology research studies and clinical trials. Supports multi-observer studies, scoring protocols and structured data export.
Regulatory clearances and approvals for AI-based pathology tools across major jurisdictions.
| Product | Company | Clearance Date | Intended Use | Predicate Device |
|---|---|---|---|---|
| Paige Prostate | Paige AI | September 2021 | Detection of areas suspicious for prostate cancer in H&E whole slide images | First-of-kind (De Novo) |
| Philips IntelliSite Pathology Solution | Philips | April 2017 | Primary diagnostic review of surgical pathology slides | First-of-kind (De Novo) |
| Aperio AT2 DX System | Leica Biosystems | March 2019 | Viewing and review of digital surgical pathology slides | Philips IntelliSite |
| Sectra Digital Pathology Module | Sectra | 2022 | Display and management of digital pathology images | Philips IntelliSite |
| Product | Company | Application | Status |
|---|---|---|---|
| Galen Platform | Ibex Medical Analytics | Cancer detection (prostate, breast, gastric) | CE-IVD; deployed in clinical labs |
| Lunit SCOPE | Lunit | PD-L1, HER2, immune phenotyping | CE-IVD |
| Paige Prostate / Breast | Paige AI | Cancer detection | CE-IVD |
| Aiforia Clinical | Aiforia Technologies | Custom clinical AI models | CE-IVD |
| NanoZoomer series | Hamamatsu | Whole slide scanning | CE-IVD |
| Product | Company | Application | SFDA Status |
|---|---|---|---|
| Philips IntelliSite | Philips | Digital pathology primary diagnosis | SFDA Registered |
| Aperio GT 450 | Leica Biosystems | Whole slide scanning | SFDA Registered |
| Sectra Digital Pathology | Sectra | Pathology image management | SFDA Registered |
Regulatory data reflects publicly available information as of July 2026. Check with manufacturers and regulatory authorities for the most current clearance and approval status.
Side-by-side comparison of all reviewed AI pathology platforms across key decision criteria.
| Platform | Regulatory | Cancer Types | Deployment | Pricing Model | Scanner Compatibility | LIS Integration | Use Case |
|---|---|---|---|---|---|---|---|
| Paige AI | FDA, CE-IVD | Prostate, Breast | Cloud + On-prem | Per-case / Subscription | Multi-scanner | Yes (HL7, API) | Clinical |
| PathAI | Pending | Multi-cancer, Biomarkers | Cloud | Enterprise / Per-study | Scanner-agnostic | API-based | Research + Trials |
| Ibex Medical | CE-IVD | Prostate, Breast, Gastric | On-prem + Cloud | Per-case | Philips, Hamamatsu, Leica | Yes | Clinical |
| Lunit | CE-IVD | IHC Biomarkers (PD-L1, HER2) | Cloud + On-prem | Per-case / Licence | Multi-scanner | Yes | Clinical + Dx |
| Aiforia | CE-IVD (Clinical) | Customisable | Cloud | Subscription | Scanner-agnostic | API-based | Research + Clinical |
| Proscia | FDA/CE pathway | Platform-dependent | Cloud + Hybrid | Enterprise licence | Vendor-neutral | Yes (HL7, DICOM) | Enterprise workflow |
| Hamamatsu | FDA, CE-IVD | Scanner + AI modules | On-prem | Capital purchase | Proprietary + open API | NDP.serve integration | Clinical + Research |
| Sectra | FDA, CE | AI marketplace | On-prem + Hybrid | Enterprise licence | Vendor-neutral | Full PACS/LIS/EHR | Enterprise clinical |
Platform capabilities and pricing models are subject to change. This comparison is intended as a general guide for initial evaluation.
A structured approach to evaluating and selecting AI tools for your laboratory or institution.
Define the specific diagnostic challenges you are solving. Identify target cancers, biomarkers, and case volumes. Determine whether the primary use case is screening, quality assurance, quantification, or primary diagnosis.
Assess your existing digital pathology infrastructure. Evaluate network bandwidth, storage capacity, scanner compatibility, and whether cloud, on-premise, or hybrid deployment best fits your organisation.
Confirm that the platform holds the appropriate regulatory clearance for your jurisdiction. FDA 510(k) for the United States, CE-IVD under IVDR for the European Union, SFDA for Saudi Arabia, and equivalent approvals for other markets.
Calculate the full cost including licensing fees, infrastructure upgrades, scanner acquisition, storage, training, validation studies, and ongoing maintenance. Compare per-case pricing against enterprise subscription models.
Plan for pathologist training, competency assessment, and clinical validation. Establish a validation protocol aligned with CAP, RCPath or local guidelines. Consider the learning curve and change management needs.